ASPE 10% owner reported $15 million purchase
The scale of the reported purchase is a notable positive insider signal, though the filing alone does not establish future performance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The scale of the reported purchase is a notable positive insider signal, though the filing alone does not establish future performance.
What happened, with direct paths to the underlying reporting
ORBIMED ADVISORS LLC reported purchasing 1,000,000 ASPE shares at $15 per share, a substantial disclosed buy that is directionally bullish.
Insider: ORBIMED ADVISORS LLC
Role: director, 10 percent owner:
Transaction: P-Purchase
Shares: 1,000,000
Price: $15
Value: $15,000,000
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.